US Patent No. 9,164,094

Biomarkers to identify HIV-specific T-cell subsets
Oct 23, 2015

Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and the General Hospital have been awarded US Patent No. 9,164,094, "Biomarkers to identify HIV-specific T-cell subsets."

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

Sponsored by

This webinar will discuss a validation study for a next-generation sequencing (NGS) assay for hematological malignancies (e.g., acute myeloid leukemia, acute lymphocytic leukemia, myelodysplastic syndrome, and myeloproliferative neoplasms).